Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 2 of 2 for “"Repatha"”.

  1. The efficacy and cost-effectiveness of evolocumab in the prevention of cardiovascular disease

    … protein in LDL receptor metabolism. Evolocumab (Repatha, AMGEN) is a human monoclonal antibody against human PSCK9. Evolocumab is approved to lower LDL-cholesterol in adult patients who have, despite dietary and lifestyle changes and maximally tolerated statin dose continued suboptimal lipid …

    bu Repository record for The efficacy and cost-effectiveness of evolocumab in the prevention of cardiovascular disease (opens in a new tab)

  2. An integrated analysis of the cancer cell secretome reveals PCSK9 as a potential co-target in pancreatic ductal adenocarcinoma.

    … monoclonal antibody inhibitor evolocumab (Repatha®), which significantly reduced tumour growth and increased survival in combination with gemcitabine/Abraxane in subcutaneous PDAC models. Multiphoton microscopy of the FUCCI cell cycle reporter demonstrated a significant stalling of KPC …

    unsw Repository record for An integrated analysis of the cancer cell secretome reveals PCSK9 as a potential co-target in pancreatic ductal adenocarcinoma. (opens in a new tab)